Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this FDA Warning Letter issued October 1, 2018 to Ignatius P. Godoy, M.D. concerns biologics products. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning pertains to the biologics regulatory category, though the specific issuing office and violation count are not documented in this metadata summary.